Cargando…

Testicular Cancer and Cryptorchidism

The failure of testicular descent or cryptorchidism is the most common defect in newborn boys. The descent of the testes during development is controlled by insulin-like 3 peptide and steroid hormones produced in testicular Leydig cells, as well as by various genetic and developmental factors. While...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferguson, Lydia, Agoulnik, Alexander I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602796/
https://www.ncbi.nlm.nih.gov/pubmed/23519268
http://dx.doi.org/10.3389/fendo.2013.00032
_version_ 1782263595994710016
author Ferguson, Lydia
Agoulnik, Alexander I.
author_facet Ferguson, Lydia
Agoulnik, Alexander I.
author_sort Ferguson, Lydia
collection PubMed
description The failure of testicular descent or cryptorchidism is the most common defect in newborn boys. The descent of the testes during development is controlled by insulin-like 3 peptide and steroid hormones produced in testicular Leydig cells, as well as by various genetic and developmental factors. While in some cases the association with genetic abnormalities and environmental causes has been shown, the etiology of cryptorchidism remains uncertain. Cryptorchidism is an established risk factor for infertility and testicular germ cell tumors (TGCT). Experimental animal models suggest a causative role for an abnormal testicular position on the disruption of spermatogenesis however the link between cryptorchidism and TGCT is less clear. The most common type of TGCT in cryptorchid testes is seminoma, believed to be derived from pluripotent prenatal germ cells. Recent studies have shown that seminoma cells and their precursor carcinoma in situ cells express a number of spermatogonial stem cell (SSC) markers suggesting that TGCTs might originate from adult stem cells. We review here the data on changes in the SSC somatic cell niche observed in cryptorchid testes of mouse models and in human patients. We propose that the misregulation of growth factors’ expression may alter the balance between SSC self-renewal and differentiation and shift stem cells toward neoplastic transformation.
format Online
Article
Text
id pubmed-3602796
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-36027962013-03-21 Testicular Cancer and Cryptorchidism Ferguson, Lydia Agoulnik, Alexander I. Front Endocrinol (Lausanne) Endocrinology The failure of testicular descent or cryptorchidism is the most common defect in newborn boys. The descent of the testes during development is controlled by insulin-like 3 peptide and steroid hormones produced in testicular Leydig cells, as well as by various genetic and developmental factors. While in some cases the association with genetic abnormalities and environmental causes has been shown, the etiology of cryptorchidism remains uncertain. Cryptorchidism is an established risk factor for infertility and testicular germ cell tumors (TGCT). Experimental animal models suggest a causative role for an abnormal testicular position on the disruption of spermatogenesis however the link between cryptorchidism and TGCT is less clear. The most common type of TGCT in cryptorchid testes is seminoma, believed to be derived from pluripotent prenatal germ cells. Recent studies have shown that seminoma cells and their precursor carcinoma in situ cells express a number of spermatogonial stem cell (SSC) markers suggesting that TGCTs might originate from adult stem cells. We review here the data on changes in the SSC somatic cell niche observed in cryptorchid testes of mouse models and in human patients. We propose that the misregulation of growth factors’ expression may alter the balance between SSC self-renewal and differentiation and shift stem cells toward neoplastic transformation. Frontiers Media S.A. 2013-03-20 /pmc/articles/PMC3602796/ /pubmed/23519268 http://dx.doi.org/10.3389/fendo.2013.00032 Text en Copyright © 2013 Ferguson and Agoulnik. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Endocrinology
Ferguson, Lydia
Agoulnik, Alexander I.
Testicular Cancer and Cryptorchidism
title Testicular Cancer and Cryptorchidism
title_full Testicular Cancer and Cryptorchidism
title_fullStr Testicular Cancer and Cryptorchidism
title_full_unstemmed Testicular Cancer and Cryptorchidism
title_short Testicular Cancer and Cryptorchidism
title_sort testicular cancer and cryptorchidism
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602796/
https://www.ncbi.nlm.nih.gov/pubmed/23519268
http://dx.doi.org/10.3389/fendo.2013.00032
work_keys_str_mv AT fergusonlydia testicularcancerandcryptorchidism
AT agoulnikalexanderi testicularcancerandcryptorchidism